These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 29890213)
1. Pathologic role of nitrergic neurotransmission in mood disorders. Ghasemi M; Claunch J; Niu K Prog Neurobiol; 2019 Feb; 173():54-87. PubMed ID: 29890213 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide: Antidepressant mechanisms and inflammation. Ghasemi M Adv Pharmacol; 2019; 86():121-152. PubMed ID: 31378250 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders. Ghasemi M; Phillips C; Fahimi A; McNerney MW; Salehi A Neurosci Biobehav Rev; 2017 Sep; 80():555-572. PubMed ID: 28711661 [TBL] [Abstract][Full Text] [Related]
4. Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems. Joca SR; Ferreira FR; Guimarães FS Stress; 2007 Aug; 10(3):227-49. PubMed ID: 17613938 [TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptors in the control of mood disorders. Witkin JM; Marek GJ; Johnson BG; Schoepp DD CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):87-100. PubMed ID: 17430147 [TBL] [Abstract][Full Text] [Related]
6. Inflamed moods: a review of the interactions between inflammation and mood disorders. Rosenblat JD; Cha DS; Mansur RB; McIntyre RS Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():23-34. PubMed ID: 24468642 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Kiss JP; Vizi ES Trends Neurosci; 2001 Apr; 24(4):211-5. PubMed ID: 11250004 [TBL] [Abstract][Full Text] [Related]
9. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs. Quesseveur G; Gardier AM; Guiard BP Curr Drug Targets; 2013 Oct; 14(11):1277-94. PubMed ID: 24020973 [TBL] [Abstract][Full Text] [Related]
11. The role of NMDA receptors in the pathophysiology and treatment of mood disorders. Ghasemi M; Phillips C; Trillo L; De Miguel Z; Das D; Salehi A Neurosci Biobehav Rev; 2014 Nov; 47():336-58. PubMed ID: 25218759 [TBL] [Abstract][Full Text] [Related]
12. A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance? Abrial E; Lucas G; Scarna H; Haddjeri N; Lambás-Señas L Mol Neurobiol; 2011 Dec; 44(3):407-19. PubMed ID: 21983961 [TBL] [Abstract][Full Text] [Related]
13. Astroglial Connexin43 as a Potential Target for a Mood Stabiliser. Okada M; Oka T; Nakamoto M; Fukuyama K; Shiroyama T Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396966 [TBL] [Abstract][Full Text] [Related]
15. Monoamine neurocircuitry in depression and strategies for new treatments. Hamon M; Blier P Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950 [TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide in the regulation of monoaminergic neurotransmission. Kiss JP Brain Res Bull; 2000 Aug; 52(6):459-66. PubMed ID: 10974484 [TBL] [Abstract][Full Text] [Related]